Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies

Kelly J. Norsworthy, Eunpi Cho, Jyoti Arora, Jeanne Kowalski, Hua Ling Tsai, Erica Warlick, Margaret Showel, Keith W. Pratz, Lesley A. Sutherland, Steven D. Gore, Anna Ferguson, Sarah Sakoian, Jackie Greer, Igor Espinoza-Delgado, Richard J. Jones, William H. Matsui, B. Douglas Smith